Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
Clinical trial NCT03197012 · COMPLETED
Trial details
- NCT number
- NCT03197012
- Sponsor
- Thomas Hope
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-05-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.